Monopolies are often an obstacle between people and the lifesaving health tools they need. Patents and other exclusivities limit supply and keep prices high.
The COVID-19 pandemic has shown we need new rules that can help every country address the fast-growing medical needs during a major global health crisis.
Over 100 countries at the World Trade Organization (WTO) supported a proposal to temporarily waive patents, trade secrets and other intellectual property (IP) on all COVID-19 medical tools.
The struggle for fair access to medicines has been struck a terrible blow following the adoption by the World Trade Organization (WTO) last week of an inadequate text rather than the originally proposed “TRIPS Waiver” on COVID monopolies, championed by MSF, civil society and over 100 countries.